{"id":"W3090413519","doi":"10.1001/jamaoncol.2020.4564","title":"Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1212,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Tolerability; Internal medicine; Sorafenib; Hepatocellular carcinoma; Adverse effect; Randomized controlled trial; Surgery; Gastroenterology; Oncology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001429736,0.0004667157,0.001288622,0.0003532481,0.000293223,0.0005256838,0.0003320083,0.0005718446,0.001475798],"category_scores_gemma":[0.001680006,0.0003651912,0.001158168,0.000303328,0.0004434832,0.0004753037,0.0002542325,0.0008947503,0.0002775595],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007279724,"about_ca_system_score_gemma":0.0007731646,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005196552,"about_ca_topic_score_gemma":0.001135311,"domain_scores_codex":[0.9994438,0.0002864531,0.00005093318,0.0000904168,0.00005584439,0.000072573],"domain_scores_gemma":[0.9991223,0.0002475106,0.0002480435,0.00005616992,0.00003948209,0.0002864583],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8177891,0.0115233,0.07341879,0.0004614042,0.002435317,0.0001778841,0.0001533948,0.001666582,0.01076629,0.00008501827,0.001132646,0.08039024],"study_design_scores_gemma":[0.3518758,0.414547,0.2186208,0.0001318819,0.003074599,0.000555144,0.0001278086,0.004436923,0.003821759,0.0004058475,0.002335088,0.00006727888],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978688,0.00134669,0.00008740079,0.000100951,0.00003482304,0.0001366599,0.0001013372,0.00001207513,0.0003111496],"genre_scores_gemma":[0.9989911,0.0003400563,0.0001292822,0.000107324,0.0000551082,0.0001229431,0.0001193312,0.000001824125,0.0001330467],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001475798,"threshold_uncertainty_score":0.007561266,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.023995485520902,"score_gpt":0.2317533058969982,"score_spread":0.2077578203760962,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}